Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1/2 5Phase 1 4Phase 3 3Phase 2/3 1

Status

Unknown 3Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Bladder Cancer 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Pharmaceutical Preparations × Clear all
NCT02973685 2023-06-12

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Sun Yat-sen University

Phase 3 Completed
315 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00210353 2019-06-06

Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma

International Extranodal Lymphoma Study Group (IELSG)

Phase 3 Completed
454 enrolled 16 charts
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT01734798 2012-11-28

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

Cairo University

Phase 3 Completed
198 enrolled
Genitourinary

Locally Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡